Silicon-nanowire-based nanocarriers with ultrahigh drug-loading capacity for in vitro and in vivo cancer therapy.
about
Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.Applications of zero-valent silicon nanostructures in biomedicine.Programming cancer through phase-functionalized silicon based biomaterials.pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug releaseTwo-dimensional graphene analogues for biomedical applications.Silicon nanostructures for cancer diagnosis and therapy.Multi-synergetic ZnO platform for high performance cancer therapy.Label-Free Virus Capture and Release by a Microfluidic Device Integrated with Porous Silicon Nanowire Forest.In Vitro Study of Receptor-Mediated Silica Nanoparticles Delivery across Blood-Brain Barrier.Degradable Hollow Mesoporous Silicon/Carbon Nanoparticles for Photoacoustic Imaging-Guided Highly Effective Chemo-Thermal Tumor Therapy in Vitro and in VivoNucleation and Assembly of Silica into Protein-Based Nanocomposites as Effective Anticancer Drug Carriers Using Self-Assembled Silk Protein Nanostructures as Biotemplates.Highly fluorescent, photostable, and ultrasmall silicon drug nanocarriers for long-term tumor cell tracking and in-vivo cancer therapy.Uniform magnesium silicate hollow spheres as high drug-loading nanocarriers for cancer therapy with low systemic toxicity.Subcellular-Scale Drug Transport via Ultrasound-Degradable Mesoporous Nanosilicon to Bypass Cancer Drug Resistance.Hepatoma-Targeted Radionuclide Immune Albumin Nanospheres: (131)I-antiAFPMcAb-GCV-BSA-NPs.
P2860
Q34157584-8DD3EA89-0A93-4CB3-A408-EBDBB140B6E3Q34490443-6527F90B-23E5-4680-87C2-2289A6784F7FQ35653023-93E89CAF-9BFC-407A-AE29-EBBDBF56DF21Q35984023-0FDE2B8E-FCBC-4794-B331-14A569AFA5ADQ36258999-EA32E9FB-BC07-419F-861B-5EE7E20C268FQ38292327-3A7B9B68-EF48-415D-A660-6E4ECB8E7A6FQ38541957-B8265678-084E-4882-B965-06BC5DD87B75Q38922215-E0BABE0D-0238-4666-8FE3-86EC58F2DBDDQ40441179-E74E39EF-AF3A-4943-8C32-3938BDA4B028Q41166926-C832EACB-7BD1-434A-8BCD-802AD08AFF23Q41481533-F0C3F417-9CAB-4F76-9B27-646068CCE954Q47971167-C79BC281-FBFA-4CA1-B611-1BFA7F63615FQ48699259-EF54EBFF-7113-4CC0-B68A-67916054A084Q50234830-D612DFC9-D9B5-48A1-965A-C22C938C3978Q50664203-761DCA73-CCFA-498F-8BFC-85CE3B63EB3CQ55190863-9AAA7606-F387-4C04-9895-199AC3F017CD
P2860
Silicon-nanowire-based nanocarriers with ultrahigh drug-loading capacity for in vitro and in vivo cancer therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Silicon-nanowire-based nanocar ...... ro and in vivo cancer therapy.
@en
Silicon-nanowire-based nanocar ...... ro and in vivo cancer therapy.
@nl
type
label
Silicon-nanowire-based nanocar ...... ro and in vivo cancer therapy.
@en
Silicon-nanowire-based nanocar ...... ro and in vivo cancer therapy.
@nl
prefLabel
Silicon-nanowire-based nanocar ...... ro and in vivo cancer therapy.
@en
Silicon-nanowire-based nanocar ...... ro and in vivo cancer therapy.
@nl
P2093
P2860
P356
P1476
Silicon-nanowire-based nanocar ...... ro and in vivo cancer therapy.
@en
P2093
P2860
P304
P356
10.1002/ANIE.201206737
P407
P577
2012-12-11T00:00:00Z